Measured by its ability to inhibit BMP-4-induced alkaline phosphatase production by ATDC5 mouse chondrogenic cells. The ED50 for this effect is 0.2-1 µg/mL in the presence of 30 ng/mL of rhBMP-4.
Source
Mouse myeloma cell line, NS0-derived mouse Chordin-like 2/CHRDL2 protein Gln24-Leu426, with a C-terminal 6-His tag
>95%, by SDS-PAGE under reducing conditions and visualized by silver stain.
Endotoxin Note
<0.01 EU per 1 μg of the protein by the LAL method.
Applications/Dilutions
Dilutions
Bioactivity
Theoretical MW
46 kDa. Disclaimer note: The observed molecular weight of the protein may vary from the listed predicted molecular weight due to post translational modifications, post translation cleavages, relative charges, and other experimental factors.
SDS-PAGE
50-60 kDa, reducing conditions
Publications
Read Publication using 2520-CH in the following applications:
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
12 months from date of receipt, -20 to -70 °C as supplied.
1 month, 2 to 8 °C under sterile conditions after reconstitution.
3 months, -20 to -70 °C under sterile conditions after reconstitution.
Buffer
Lyophilized from a 0.2 μm filtered solution in HCl with BSA as a carrier protein.
Purity
>95%, by SDS-PAGE under reducing conditions and visualized by silver stain.
Reconstitution Instructions
Reconstitute at 100 μg/mL in sterile PBS containing at least 0.1% human or bovine serum albumin.
Notes
This product is produced by and ships from R&D Systems, Inc., a Bio-Techne brand.
Alternate Names for Recombinant Mouse Chordin-Like 2 Protein
BNF-1
Chordin like 2
Chordin-like 2
chordin-like protein 2
CHRDL2
Background
Chordin-like 2 (CHL2, CHRDL2, or BNF-1), is an approximately 55 kDa secreted glycoprotein that acts as a BMP antagonist. Mature mouse CHL2 contains three von Willebrand type C repeats and shares 73% and 95% amino acid sequence identity with human and rat CHL2, respectively (1-3). Alternative splicing of mouse Chordin-like 2 generates additional isoforms with substituted N-terminal or C-terminal regions (3). CHL2 is expressed in chondrocytes in developing joint cartilage (2, 4), osteoblasts, myotubes, brain, some carcinomas, and the genitourinary system (e.g. uterus, prostate, testis, bladder) (1-3). CHL2 binds to multiple TGF-beta superfamily proteins including BMP-2, -4, -5, -6, -7, GDF-5, Activin A, and TSG (2, 3, 5, 6). It prevents the binding of BMPs to type 1 and type 2 receptors as well as BMP-induced cellular responses (2, 5). CHL2 reduces the rate of matrix deposition by mesenchymal cells, acting as a negative regulator of cartilage formation (2).
Wu, I. and M.A. Moses (2003) Gene 311:105.
Nakayama, N. et al. (2004) Development 131:229.
Oren, A. et al. (2004) Gene 331:17.
Lorda-Diez, C.I. et al. (2013) PLoS One 8:e60423.
Fujisawa, T. et al. (2009) Biochem. Biophys. Res. Commun. 385:215.
Zhang, J.L. et al. (2007) J. Biol. Chem. 282:20002.
The concentration calculator allows you to quickly calculate the volume, mass or concentration of your vial. Simply enter your mass, volume, or concentration values for your reagent and the calculator will determine the rest.
=
÷
Review this Product
Be the first to review our Recombinant Mouse Chordin-Like 2 Protein and receive a gift card or discount.